Receptor activator of NF-κB ligand-dependent expression of caveolin-1 in osteoclast precursors, and high dependency of osteoclastogenesis on exogenous lipoprotein

Bone

Volumn 50, Issue 1, 2012, Pages 226-236

  Hada, Naoto ^a   Okayasu, Mari ^a   Ito, Junta ^a   Nakayachi, Mai ^a   Hayashida, Chiyomi ^a   Kaneda, Toshio ^b   Uchida, Noritaka ^c   Muramatsu, Takamichi ^c   Koike, Chihiro ^c   Masuhara, Masaaki ^d   Sato, Takuya ^a   Hakeda, Yoshiyuki ^a  

^a MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

^b HOSHI UNIVERSITY   (Japan)

^c HITACHI LTD   (Japan)

^d KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Caveolin 1; Exogenous lipoprotein; Lipid raft; NFATc1; Osteoclastogenesis

Indexed keywords

CAVEOLIN 1; CHOLESTEROL; FLOTILLIN 1; LIPOPROTEIN; METHYL BETA CYCLODEXTRIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN KINASE B; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFATC1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM SIGNALING; CAVEOLA; CELL MEMBRANE; CELL NUCLEUS; CONTROLLED STUDY; CULTURE MEDIUM; CYTOSOL; ENZYME ACTIVATION; GENE EXPRESSION; IN VITRO STUDY; INTEROCULAR TRANSFER; LIPID RAFT; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOCLAST; OSTEOCLASTOGENESIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LIPID INTERACTION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; STEM CELL; TRANSCRIPTION INITIATION; WILD TYPE;

ANIMALS; BONE RESORPTION; CAVEOLIN 1; CAVEOLIN 2; GENE SILENCING; LIPOPROTEINS; MALE; MEMBRANE MICRODOMAINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NFATC TRANSCRIPTION FACTORS; OSTEOCLASTS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 81255184478     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2011.10.028     Document Type: Article

References (62)

1. Felix R., Cecchini M.G., Hofstetter W., Elford P.R., Stutzer A., Fleisch H. Impairment of macrophage colony-stimulating factor production and lack of resident bone marrow macrophages in the osteopetrotic op/op mouse. J Bone Miner Res 1990, 5:781-789.
2. Kodama H., Yamasaki A., Nose M., Niida S., Ohgame Y., Abe M., et al. Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor. J Exp Med 1991, 173:269-272.
3. Chambers T.J. The pathobiology of the osteoclast. J Clin Pathol 1985, 38:241-252.
4. Suda T., Udagawa N., Nakamura I., Miyaura C., Takahashi N. Modulation of osteoclast differentiation by local factors. Bone 1995, 17(2 Suppl.):87S-91S.
5. Lacey D.L., Timms E., Tan H.L., Kelley M.J., Dunstan C.R., Burgess T., et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998, 93:165-176.
6. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Mochizuki S., et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A 1998, 95:3597-3602.
7. Kong Y.Y., Yoshida H., Sarosi I., Tan H.L., Timms E., Capparelli C., et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999, 397:315-323.
8. Darnay B.G., Haridas V., Ni J., Moore P.A., Aggarwal B.B. Characterization of the intracellular domain of receptor activator of NF-κB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-κB and c-Jun N-terminal kinase. J Biol Chem 1998, 273:20551-20555.
9. Asagiri M., Takayanagi H. The molecular understanding of osteoclast differentiation. Bone 2007, 40:251-264.
10. Humphrey M.B., Lanier L.L., Nakamura M.C. Role of ITAM-containing adapter proteins and their receptors in the immune system and bone. Immunol Rev 2005, 208:50-65.
11. Takayanagi H., Kim S., Koga T., Nishina H., Isshiki M., Yoshida H., et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 2002, 3:889-901.
12. Ishida N., Hayashi K., Hoshijima M., Ogawa T., Koga S., Miyatake Y., et al. Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J Biol Chem 2002, 277:41147-41156.
13. Ikeda F., Nishimura R., Matsubara T., Tanaka S., Inoue J., Reddy S.V., et al. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J Clin Invest 2004, 114:475-484.
14. Matsumoto M., Kogawa M., Wada S., Takayanagi H., Tsujimoto M., Katayama S., et al. Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1. J Biol Chem 2004, 279:45969-45979.
15. Kim K., Lee S.H., Ha Kim J., Choi Y., Kim N. NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Mol Endocrinol 2008, 22:176-185.
16. Lee S.H., Rho J., Jeong D., Sul J.Y., Kim T., Kim N., et al. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat Med 2006, 12:1403-1409.
17. Cheng Z.J., Singh R.D., Marks D.L., Pagano R.E. Membrane microdomains, caveolae, and caveolar endocytosis of sphingolipids. Mol Membr Biol 2006, 23:101-110.
18. Gargalovic P., Dory L. Caveolins and macrophage lipid metabolism. J Lipid Res 2003, 44:11-21.
19. Syme C.A., Zhang L., Bisello A. Caveolin-1 regulates cellular trafficking and function of the glucagon-like Peptide 1 receptor. Mol Endocrinol 2006, 20:3400-3411.
20. Prieto-Sánchez R.M., Berenjeno I.M., Bustelo X.R. Involvement of the Rho/Rac family member RhoG in caveolar endocytosis. Oncogene 2006, 25:2961-2973.
21. Pani B., Singh B.B. Lipid rafts/caveolae as microdomains of calcium signaling. Cell Calcium 2009, 45:625-633.
22. Kinoshita M.O., Furuya S., Ito S., Shinoda Y., Yamazaki Y., Greimel P., et al. Lipid rafts enriched in phosphatidylglucoside direct astroglial differentiation by regulating tyrosine kinase activity of epidermal growth factor receptors. Biochem J 2009, 419:565-575.
23. Prior I.A., Muncke C., Parton R.G., Hancock J.F. Direct visualization of Ras proteins in spatially distinct cell surface microdomains. J Cell Biol 2003, 160:165-170.
24. Hunter I., Nixon G.F. Spatial compartmentalization of tumor necrosis factor (TNF) receptor 1-dependent signaling pathways in human airway smooth muscle cells. Lipid rafts are essential for TNF-α-mediated activation of RhoA but dispensable for the activation of the NF-κB and MAPK pathways. J Biol Chem 2006, 281(45):34705-34715.
25. Lee J.L., Wang M.J., Sudhir P.R., Chen J.Y. CD44 engagement promotes matrix-derived survival through the CD44-SRC-integrin axis in lipid rafts. Mol Cell Biol 2008, 28:5710-5723.
26. Väänänen H.K., Laitala-Leinonen T. Osteoclast lineage and function. Arch Biochem Biophys 2008, 473:132-138.
27. Teitelbaum S.L. Osteoclasts: what do they do and how do they do it?. Am J Pathol 2007, 170:427-435.
28. Ha H., Kwak H.B., Lee S.K., Na D.S., Rudd C.E., Lee Z.H., et al. Membrane rafts play a crucial role in receptor activator of nuclear factor κB signaling and osteoclast function. J Biol Chem 2003, 278:18573-18580.
29. Luegmayr E., Glantschnig H., Wesolowski G.A., Gentile M.A., Fisher J.E., Rodan G.A., et al. Osteoclast formation, survival and morphology are highly dependent on exogenous cholesterol/lipoproteins. Cell Death Differ 2004, 11(Suppl. 1):S108-S118.
30. Kaneda T., Nojima T., Nakagawa M., Ogasawara A., Kaneko H., Sato T., et al. Endogenous production of TGF-ß is essential for osteoclastogenesis induced by a combination of receptor activator of NF-κB ligand and macrophage-colony-stimulating factor. J Immunol 2000, 165(8):4254-4263.
31. Ito T., Kito K., Adati N., Mitsui Y., Hagiwara H., Sakaki Y. Fluorescent differential display: arbitrarily primed RT-PCR fingerprinting on an automated DNA sequencer. FEBS Lett 1994, 351:231-236.
32. Jobling M.G., Holmes R.K. Mutational analysis of ganglioside GM(1)-binding ability, pentamer formation, and epitopes of cholera toxin B (CTB) subunits and CTB/heat-labile enterotoxin B subunit chimeras. Infect Immun 2002, 70:1260-1271.
33. Kwak H.B., Lee B.K., Oh J., Yeon J.T., Choi S.W., Cho H.J., et al. Inhibition of osteoclast differentiation and bone resorption by rotenone, through down-regulation of RANKL-induced c-Fos and NFATc1 expression. Bone 2010, 46:724-731.
34. Asagiri M., Sato K., Usami T., Ochi S., Nishina H., Yoshida H., et al. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J Exp Med 2005, 202:1261-1269.
35. Mócsai A., Humphrey M.B., Van Ziffle J.A., Hu Y., Burghardt A., Spusta S.C., et al. The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRγ) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc Natl Acad Sci U S A 2004, 101:6158-6163.
36. Kaifu T., Nakahara J., Inui M., Mishima K., Momiyama T., Kaji M., et al. Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. J Clin Invest 2003, 111:323-332.
37. Choi S.J., Cruz J.C., Craig F., Chung H., Devlin R.D., Roodman G.D., et al. Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma. Blood 2000, 96:671-675.
38. Han J.H., Choi S.J., Kurihara N., Koide M., Oba Y., Roodman G.D. Macrophage inflammatory protein-1α is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor κB ligand. Blood 2001, 97:3349-3353.
39. Kinder M., Chislock E., Bussard K.M., Shuman L., Mastro A.M. Metastatic breast cancer induces an osteoblast inflammatory response. Exp Cell Res 2008, 314:173-183.
40. Pakuts B., Debonneville C., Liontos L.M., Loreto M.P., McGlade C.J. The Src-like adaptor protein 2 regulates colony-stimulating factor-1 receptor signaling and down-regulation. J Biol Chem 2007, 282:17953-17963.
41. Takami M., Kim N., Rho J., Choi Y. Stimulation by toll-like receptors inhibits osteoclast differentiation. J Immunol 2002, 169:1516-1523.
42. Anderson R.G. Caveolae: where incoming and outgoing messengers meet. Proc Natl Acad Sci U S A 1993, 90:10909-10913.
43. 2+-ATPase, and inositol trisphosphate receptor. Proc Natl Acad Sci U S A 1995, 92:1759-1763.
44. Razani B., Engelman J.A., Wang X.B., Schubert W., Zhang X.L., Marks C.B., et al. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 2001, 276:38121-38138.
45. Smart E.J., Ying Y., Donzell W.C., Anderson R.G. A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane. J Biol Chem 1996, 271:29427-29435.
46. Nystrom F.H., Chen H., Cong L.N., Li Y., Quon M.J. Caveolin-1 interacts with the insulin receptor and can differentially modulate insulin signaling in transfected Cos-7 cells and rat adipose cells. Mol Endocrinol 1999, 13:2013-2024.
47. Tang Z., Scherer P.E., Okamoto T., Song K., Chu C., Kohtz D.S., et al. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem 1996, 271:2255-2261.
48. Parton R.G., Way M., Zorzi N., Stang E. Caveolin-3 associates with developing T-tubules during muscle differentiation. J Cell Biol 1997, 136:137-154.
49. de Villiers W.J., Smart E.J. Macrophage scavenger receptors and foam cell formation. J Leukoc Biol 1999, 66:740-746.
50. Shinohara M., Koga T., Okamoto K., Sakaguchi S., Arai K., Yasuda H., et al. Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals. Cell 2008, 132:794-806.
51. Rubin J., Schwartz Z., Boyan B.D., Fan X., Case N., Sen B., et al. Caveolin-1 knockout mice have increased bone size and stiffness. J Bone Miner Res 2007, 22:1408-1418.
52. Scherer P.E., Lewis R.Y., Volonte D., Engelman J.A., Galbiati F., Couet J., et al. Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J Biol Chem 1997, 272:29337-29346.
53. Das K., Lewis R.Y., Scherer P.E., Lisanti M.P. The membrane-spanning domains of caveolins-1 and -2 mediate the formation of caveolin hetero-oligomers. Implications for the assembly of caveolae membranes in vivo. J Biol Chem 1999, 274:18721-18728.
54. Mizukami J., Takaesu G., Akatsuka H., Sakurai H., Ninomiya-Tsuji J., Matsumoto K., et al. Receptor activator of NF-κB ligand (RANKL) activates TAK1 mitogen-activated protein kinase through a signaling complex containing RANK, TAB2, and TRAF6. Mol Cell Biol 2002, 22:992-1000.
55. Furuchi T., Anderson R.G. Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase (ERK). J Biol Chem 1998, 273:21099-21104.
56. Woodman S.E., Park D.S., Cohen A.W., Cheung M.W., Chandra M., Shirani J., et al. Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade. J Biol Chem 2002, 277:38988-38997.
57. Sugatani T., Hruska K.A. Akt1/Akt2 and mammalian target of rapamycin/Bim play critical roles in osteoclast differentiation and survival, respectively, whereas Akt is dispensable for cell survival in isolated osteoclast precursors. J Biol Chem 2005, 280:3583-3589.
58. Gingery A., Bradley E., Shaw A., Oursler M.J. Phosphatidylinositol 3-kinase coordinately activates the MEK/ERK and AKT/NFκB pathways to maintain osteoclast survival. J Cell Biochem 2003, 89:165-179.
59. Banfić H., Tang X., Batty I.H., Downes C.P., Chen C., Rittenhouse S.E. A novel integrin-activated pathway forms PKB/Akt-stimulatory phosphatidylinositol 3,4-bisphosphate via phosphatidylinositol 3-phosphate in platelets. J Biol Chem 1998, 273:13-16.
60. Wong B.R., Besser D., Kim N., Arron J.R., Vologodskaia M., Hanafusa H., et al. TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src. Mol Cell 1999, 4:1041-1049.
61. Zhou B., Cron R.Q., Wu B., Genin A., Wang Z., Liu S., et al. Regulation of the murine Nfatc1 gene by NFATc2. J Biol Chem 2002, 277:10704-10711.
62. van Rooij E., Doevendans P.A., de Theije C.C., Babiker F.A., Molkentin J.D., de Windt L.J. Requirement of nuclear factor of activated T-cells in calcineurin-mediated cardiomyocyte hypertrophy. J Biol Chem 2002, 277:48617-48626.